Lialda Shire plc - Treatment for Ulcerative Colitis
Lialda is a once-daily oral formulation of mesalamine indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis.Posted: January 2007
Related Articles:
- Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis - July 18, 2011
